FDA panel recommends limiting Pfizer booster shots to Americans 65 and older, and those at high risk of severe COVID-19
- Written by Matthew Woodruff, Instructor of Human Immunology, Emory University
No third dose for now.AP Photo/Robert F. BukatyThe key scientific advisory council of the Food and Drug Administration has voted to deny use of a “booster” shot of Pfizer’s mRNA vaccine to the general public – a move that will likely disappoint some public health experts pushing for a third dose to help slow the spread of...

















